Delek US Holdings enters the final days of May caught between two competing signals: a dramatic squeeze in short positioning over the past month and a cluster of insider selling that has accelerated just as the stock recovered.
The short interest story is the most striking data point of the month. SI fell from a peak of 16.1% of the free float on May 1 to 10.7% today — a drop of roughly a third in under four weeks. That is not a small move. The mass of short covering came precisely as the stock rallied, with the bulk of the unwind occurring between May 1 and May 11. Since then, the position has stabilised in a narrow 10.7–10.9% band. Borrow is essentially free — cost to borrow is running near 0.40% annualised — and availability is extraordinarily loose at over 3,300% of outstanding short interest, meaning there is no squeeze pressure and new short positions can be put on without friction. The options market echoes the same cautious-but-not-alarmed read. The put/call ratio is 0.61, well below its 20-day average of 1.92, and roughly 1.4 standard deviations below the mean — a sharp swing from mid-May, when the PCR was running above 2.5 for two weeks straight. Call activity has dominated recently, consistent with the short covering that pulled the position lower.
Against that backdrop, the insider activity stands out. Chairman Ezra Yemin sold more than $3.4 million of stock across multiple tranches between April 29 and May 4, when the price was in the $44–$47 range. The CFO sold $443,600 on May 18. The Deputy CFO sold $504,000 on May 13. A director sold in the same week. Net insider sales over the 90-day window total nearly $13.1 million. That is a concentrated, multi-executive selling programme that coincides almost exactly with the stock's recovery from its April lows — and it is hard to read as routine portfolio management.
The Street has been incrementally more constructive on DK. Mizuho raised its target today to $60 from $54 while keeping an Outperform rating. Goldman Sachs carries a Buy with a $55 target (raised from $43 in April). Wells Fargo holds Overweight with a $59 target. On the other side, TD Cowen cut its target to $44 from $60 in late April while holding Hold, and Morgan Stanley's Equal-Weight rating comes with a $40 target — below the current price of $42.75. The mean price target of $50.31 implies roughly 18% upside from here, though the spread between bulls and bears is unusually wide. Factor scores support the bull case selectively: EPS momentum over 30 days ranks in the 97th percentile and EPS surprise in the 88th, but 90-day EPS momentum sits at the 1st percentile — a stark reversal that may partly explain why analysts remain divided.
Sector peers have been uniformly weak this week. PBF fell 9.2%, CVI dropped 8.3%, and CHRD shed 7.8%. DK itself is down 6.1% on the week, roughly in line with the refining complex. VLO fell 6.6% while MPC lost 4.4%, and DINO held up best at -2.5%. The uniform weakness points to crack spread pressure and macro headwinds rather than anything company-specific in the near term.
The last two earnings prints have moved sharply in opposite directions: the April 29 print sparked a 13.5% one-day rally and a 9.6% five-day gain, while the May 5 report produced a 6.3% one-day decline. The next scheduled release is August 4. How the refining margin environment develops between now and then — and whether insider selling intensifies or pauses — will define the next chapter for the stock.
See the live data behind this article on ORTEX.
Open DK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
